Shareholder Q&A, page-9

I no expert but hear is my 2c.

1. They should have possible trial design ready to take to meeting and double blind with placebo and lowest number they think they will get away with. Will these trials meet FDA requirement as well?
2. Recruitment would be quicker than some trials as it is a very common disease.
3. Product would be of existing IV stock. Large inventory listed in financial accounts and product is not being changed.
4. 12 weeks maybe more hopefully 90D is acceptable.
5. Do SAWP approve the data or just design the test?

6 months best case?

More money probably 10M less a bit now. How is that R&D claim looking?